by Dennis Crouch
This article analyzes some of the latest developments in the ongoing legal battle between medical device company Masimo and tech giant Apple regarding Apple's adjudged infringement of Masimo's pulse oximetry patents in its Apple Watch. The basic question is whether Masimo's pulse-oximetry patents will be strong enough to stop the Apple juggernaut.
To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.